Classification Information
pharmaceutical products for the treatment of central nervous system diseases and disorders; pharmaceutical products for the treatment of vertigo, dizziness, and lightheadedness; pharmaceutical products for the treatment of symptomatic neurogenic orthostatic hypotension; pharmaceutical products for the treatment of symptoms caused by primary autonomic failure, dopamine beta-hydroxylase deficiency, and non-diabetic autonomic neuropathy; pharmaceutical products for the treatment of symptoms caused by Parkinson’s disease, multiple system atrophy, and pure autonomic failure
Pharmaceuticals